temozolomide has been researched along with Chronic Kidney Failure in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide was successfully up-titrated to the full dose." | 1.91 | Safe administration of temozolomide in end-stage renal disease patients. ( Hundal, J; Pereira, MK; Singh, A; Vredenburg, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hundal, J | 3 |
| Singh, A | 3 |
| Pereira, MK | 3 |
| Vredenburg, J | 3 |
1 other study available for temozolomide and Chronic Kidney Failure
| Article | Year |
|---|---|
Safe administration of temozolomide in end-stage renal disease patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Central Nervous System Neoplasms; Glioblastoma; | 2023 |
Safe administration of temozolomide in end-stage renal disease patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Central Nervous System Neoplasms; Glioblastoma; | 2023 |
Safe administration of temozolomide in end-stage renal disease patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Central Nervous System Neoplasms; Glioblastoma; | 2023 |
Safe administration of temozolomide in end-stage renal disease patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Central Nervous System Neoplasms; Glioblastoma; | 2023 |